ATAI
Price
$1.39
Change
-$0.01 (-0.71%)
Updated
May 9 closing price
Capitalization
279.71M
10 days until earnings call
CABA
Price
$1.19
Change
-$0.02 (-1.65%)
Updated
May 9 closing price
Capitalization
61.4M
4 days until earnings call
Ad is loading...

ATAI vs CABA

Header iconATAI vs CABA Comparison
Open Charts ATAI vs CABABanner chart's image
ATAI Life Sciences
Price$1.39
Change-$0.01 (-0.71%)
Volume$1.08M
Capitalization279.71M
Cabaletta Bio
Price$1.19
Change-$0.02 (-1.65%)
Volume$372.4K
Capitalization61.4M
ATAI vs CABA Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. CABA commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and CABA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (ATAI: $1.39 vs. CABA: $1.19)
Brand notoriety: ATAI and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 67% vs. CABA: 46%
Market capitalization -- ATAI: $279.71M vs. CABA: $61.4M
ATAI [@Biotechnology] is valued at $279.71M. CABA’s [@Biotechnology] market capitalization is $61.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATAI and CABA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 3 TA indicator(s) are bullish while CABA’s TA Score has 5 bullish TA indicator(s).

  • ATAI’s TA Score: 3 bullish, 6 bearish.
  • CABA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CABA is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а -7.33% price change this week, while CABA (@Biotechnology) price change was -11.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

CABA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($280M) has a higher market cap than CABA($61.4M). ATAI YTD gains are higher at: 4.511 vs. CABA (-47.577). CABA has higher annual earnings (EBITDA): -112.92M vs. ATAI (-124.33M). CABA has more cash in the bank: 183M vs. ATAI (85.9M). CABA has less debt than ATAI: CABA (15.2M) vs ATAI (23.8M). ATAI has higher revenues than CABA: ATAI (331K) vs CABA (0).
ATAICABAATAI / CABA
Capitalization280M61.4M456%
EBITDA-124.33M-112.92M110%
Gain YTD4.511-47.577-9%
P/E RatioN/AN/A-
Revenue331K0-
Total Cash85.9M183M47%
Total Debt23.8M15.2M157%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
78

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICABA
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVEO20.920.26
+1.26%
Civeo Corp
OGE44.380.04
+0.09%
OGE Energy Corp
UL62.50-0.08
-0.13%
Unilever plc
GETY1.88-0.04
-2.08%
Getty Images Holdings
APLT0.40-0.01
-2.44%
Applied Therapeutics

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-0.71%
MNMD - ATAI
51%
Loosely correlated
-4.80%
CRSP - ATAI
47%
Loosely correlated
-1.44%
RXRX - ATAI
47%
Loosely correlated
-1.37%
ABCL - ATAI
47%
Loosely correlated
+1.00%
CYBN - ATAI
46%
Loosely correlated
+6.33%
More

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-1.65%
KYTX - CABA
47%
Loosely correlated
-0.94%
IMNM - CABA
44%
Loosely correlated
-3.24%
ARWR - CABA
43%
Loosely correlated
-1.66%
CCCC - CABA
42%
Loosely correlated
-4.55%
IPSC - CABA
41%
Loosely correlated
+3.27%
More